Home
CRSP
CRSP News

Latest CRISPR Therapeutics AG (CRSP) News on February 22, 2025

CRISPR Therapeutics AG (CRSP): Among the Most Oversold Healthcare Stocks to Buy Now

Insider Monkey

2 days ago

CRISPR Therapeutics AG (CRSP): Among the Most Oversold Healthcare Stocks to Buy Now

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

2 days ago

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?

Zacks

4 days ago

CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?

Investing.com

6 days ago

Street Calls of the Week

Why CRISPR Therapeutics (CRSP) Soared on Friday?

Insider Monkey

7 days ago

Why CRISPR Therapeutics (CRSP) Soared on Friday?

CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99

GuruFocus.com

8 days ago

CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99

CRISPR Therapeutics Stock Upgrade Following Analyst Reassessment

GuruFocus.com

8 days ago

CRISPR Therapeutics Stock Upgrade Following Analyst Reassessment

Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday

Motley Fool

9 days ago

Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday

Morningstar Research

10 days ago

Analyst Report: CRISPR Therapeutics AG

Crispr Therapeutics price target raised to $86 from $85 at BofA

TipRanks

10 days ago

Crispr Therapeutics price target raised to $86 from $85 at BofA

CRISPR Therapeutics Q4 Earnings and Revenues Surpass Estimates

Zacks

10 days ago

CRISPR Therapeutics Q4 Earnings and Revenues Surpass Estimates

MT Newswires

10 days ago

Truist Securities Adjusts Price Target on CRISPR Therapeutics to $120 From $100, Keeps Buy Rating

MT Newswires

10 days ago

TD Cowen Upgrades CRISPR Therapeutics to Hold From Sell, Adjusts Price Target to $35 From $30

MT Newswires

10 days ago

RBC Lowers Price Target on CRISPR Therapeutics to $48 From $53, Keeps Sector Perform, Speculative Risk

MT Newswires

10 days ago

CRISPR Therapeutics Swings to Q4 Loss, Revenue Falls

CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Tops Revenue Estimates

Zacks

10 days ago

CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Tops Revenue Estimates

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

10 days ago

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

MT Newswires

11 days ago

BofA Securities Adjusts CRISPR Therapeutics Price Target to $86 From $85, Maintains Buy Rating

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

Zacks

11 days ago

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move

Motley Fool

12 days ago

Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move

CRISPR Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?

Zacks

15 days ago

CRISPR Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?

CRISPR Therapeutics AG (CRSP): Among Cathie Wood’s Top Stock Picks for 2025

Insider Monkey

15 days ago

CRISPR Therapeutics AG (CRSP): Among Cathie Wood’s Top Stock Picks for 2025

The Zacks Analyst Blog Highlights Amgen, CRISPR, Moderna, Sarepta and Vertex

Zacks

16 days ago

The Zacks Analyst Blog Highlights Amgen, CRISPR, Moderna, Sarepta and Vertex

Why CRISPR Therapeutics AG (CRSP) Outpaced the Stock Market Today

Zacks

17 days ago

Why CRISPR Therapeutics AG (CRSP) Outpaced the Stock Market Today

Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates?

Zacks

19 days ago

Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates?

MT Newswires

19 days ago

HC Wainwright Initiates CRISPR Therapeutics at Buy With $65 Price Target

Jim Cramer Says “CRISPR (CRSP) Keeps Losing Money Like Moderna” – Here’s Why

Insider Monkey

23 days ago

Jim Cramer Says “CRISPR (CRSP) Keeps Losing Money Like Moderna” – Here’s Why

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors

Zacks

23 days ago

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors

CRISPR Therapeutics to Present at the Guggenheim SMID Cap Biotech Conference

GlobeNewswire

24 days ago

CRISPR Therapeutics to Present at the Guggenheim SMID Cap Biotech Conference

CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know

CRISPR Therapeutics (CRSP) Moves 6.5% Higher: Will This Strength Last?

Zacks

a month ago

CRISPR Therapeutics (CRSP) Moves 6.5% Higher: Will This Strength Last?

My Top 5 Stocks to Buy in Early 2025

Motley Fool

a month ago

My Top 5 Stocks to Buy in Early 2025

CRISPR Therapeutics AG (CRSP): The Biotech Stock with Biggest Upside Potential

Insider Monkey

a month ago

CRISPR Therapeutics AG (CRSP): The Biotech Stock with Biggest Upside Potential

CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell?

Zacks

a month ago

CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell?

2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows

Motley Fool

a month ago

2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows

My 10 Top Stocks to Buy to Start the New Year Off Right

Motley Fool

a month ago

My 10 Top Stocks to Buy to Start the New Year Off Right

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

Meet the Innovative Growth Stock That Could Rocket 114% to 152% Higher in 2025, According to a Couple of Wall Street Analysts

Motley Fool

a month ago

Meet the Innovative Growth Stock That Could Rocket 114% to 152% Higher in 2025, According to a Couple of Wall Street Analysts

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2025 Milestones

GlobeNewswire

a month ago

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2025 Milestones

3 Mid-Cap Stocks That Could Take Off in 2025

Motley Fool

a month ago

3 Mid-Cap Stocks That Could Take Off in 2025

CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a month ago

CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note

MT Newswires

a month ago

BofA Securities Adjusts Price Target on CRISPR Therapeutics to $85 From $98, Maintains Buy Rating

CRISPR Therapeutics Proposes New Appointment to the Board of Directors

GlobeNewswire

a month ago

CRISPR Therapeutics Proposes New Appointment to the Board of Directors

Vertex, startup Orna to partner on gene editing research

BioPharma Dive

a month ago

Vertex, startup Orna to partner on gene editing research

CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know

Why Is CRISPR Therapeutics AG (CRSP) Among the Top CRISPR Stocks to Invest In?

Insider Monkey

2 months ago

Why Is CRISPR Therapeutics AG (CRSP) Among the Top CRISPR Stocks to Invest In?

CRISPR Therapeutics AG (CRSP): Is This Gene Therapy Stock a Good Buy Right Now?

Insider Monkey

2 months ago

CRISPR Therapeutics AG (CRSP): Is This Gene Therapy Stock a Good Buy Right Now?

CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information for Investors

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information for Investors

Institutional investors may adopt severe steps after CRISPR Therapeutics AG's (NASDAQ:CRSP) latest 8.3% drop adds to a year losses

Simply Wall St.

2 months ago

Institutional investors may adopt severe steps after CRISPR Therapeutics AG's (NASDAQ:CRSP) latest 8.3% drop adds to a year losses

Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term

Zacks

2 months ago

Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term

This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy?

Motley Fool

2 months ago

This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy?

1 big new Green Flag for CRISPR Therapeutics' Stock

Motley Fool

2 months ago

1 big new Green Flag for CRISPR Therapeutics' Stock

3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025

Zacks

2 months ago

3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025

2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?

Motley Fool

2 months ago

2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?

3 Things You Need to Know if You Buy CRISPR Therapeutics Today

Motley Fool

2 months ago

3 Things You Need to Know if You Buy CRISPR Therapeutics Today

Editas to lay off staff after search for sickle cell partner comes up empty

BioPharma Dive

2 months ago

Editas to lay off staff after search for sickle cell partner comes up empty

Is CRISPR Therapeutics AG (CRSP) the Worst ARK Stock to Buy According to Short Sellers?

Insider Monkey

2 months ago

Is CRISPR Therapeutics AG (CRSP) the Worst ARK Stock to Buy According to Short Sellers?

MT Newswires

2 months ago

CRISPR Therapeutics Says Trial Data Show CTX112 Has 'Potential' to Treat Malignancies

CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting

GlobeNewswire

2 months ago

CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting

2 Biotech Stocks to Buy Hand Over Fist in December

Motley Fool

2 months ago

2 Biotech Stocks to Buy Hand Over Fist in December

CRISPR Therapeutics (CRSP) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

3 months ago

CRISPR Therapeutics (CRSP) Upgraded to Buy: What Does It Mean for the Stock?

Why Is CRISPR Therapeutics (CRSP) Up 0.8% Since Last Earnings Report?

Zacks

3 months ago

Why Is CRISPR Therapeutics (CRSP) Up 0.8% Since Last Earnings Report?

3 of the Best Growth Stocks You Can Buy for Less than $100

Motley Fool

3 months ago

3 of the Best Growth Stocks You Can Buy for Less than $100

Wall Street Analysts Think CRISPR Therapeutics (CRSP) Could Surge 58.3%: Read This Before Placing a Bet

Zacks

3 months ago

Wall Street Analysts Think CRISPR Therapeutics (CRSP) Could Surge 58.3%: Read This Before Placing a Bet

Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%

Motley Fool

3 months ago

Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%

Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip?

Motley Fool

3 months ago

Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip?

3 Monster Stocks in the Making

Motley Fool

3 months ago

3 Monster Stocks in the Making

Why Is CRISPR Therapeutics AG (CRSP) Among the Worst Performing Biotech Stocks in 2024?

Insider Monkey

3 months ago

Why Is CRISPR Therapeutics AG (CRSP) Among the Worst Performing Biotech Stocks in 2024?

CRISPR Therapeutics Stock Falls 7% in Two Weeks: Time to Hold or Sell?

Zacks

3 months ago

CRISPR Therapeutics Stock Falls 7% in Two Weeks: Time to Hold or Sell?

CRISPR Therapeutics AG (CRSP): Among the Best Genomics Stocks to Buy Right Now

Insider Monkey

3 months ago

CRISPR Therapeutics AG (CRSP): Among the Best Genomics Stocks to Buy Right Now

CRISPR therapy from Intellia may ameliorate rare heart disorder, data suggest

BioPharma Dive

3 months ago

CRISPR therapy from Intellia may ameliorate rare heart disorder, data suggest

CRISPR Therapeutics AG (CRSP): Among ARK Invest’s Top Stock Picks for 2024

Insider Monkey

3 months ago

CRISPR Therapeutics AG (CRSP): Among ARK Invest’s Top Stock Picks for 2024

2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More

Motley Fool

3 months ago

2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More

Where Will CRISPR Therapeutics Be in 3 Years?

Motley Fool

3 months ago

Where Will CRISPR Therapeutics Be in 3 Years?

CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference

GlobeNewswire

3 months ago

CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference

3 Unstoppable Growth Stocks I'm Loading $25,000 Each Into by 2029

Motley Fool

3 months ago

3 Unstoppable Growth Stocks I'm Loading $25,000 Each Into by 2029

Elon Musk will be 'vitally important' in Trump admin: Cathie Wood

Yahoo Finance Video

3 months ago

Elon Musk will be 'vitally important' in Trump admin: Cathie Wood

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Motley Fool

3 months ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference

GlobeNewswire

3 months ago

CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference

CRISPR Therapeutics AG (NASDAQ:CRSP) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Simply Wall St.

3 months ago

CRISPR Therapeutics AG (NASDAQ:CRSP) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Morningstar Research

4 months ago

Analyst Report: CRISPR Therapeutics AG

Wall Street Analysts See a 62.75% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High?

Zacks

4 months ago

Wall Street Analysts See a 62.75% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High?

CRSP's Q3 Loss Narrower Than Expected, Sales Miss Estimates

Zacks

4 months ago

CRSP's Q3 Loss Narrower Than Expected, Sales Miss Estimates

CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates

MT Newswires

4 months ago

CRISPR Therapeutics' Q3 Net Loss Narrows

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

GlobeNewswire

4 months ago

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

3 Companies Building Tomorrow's Game-Changing Technologies

Motley Fool

4 months ago

3 Companies Building Tomorrow's Game-Changing Technologies

CRISPR Therapeutics AG (CRSP) Just Overtook the 20-Day Moving Average

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Just Overtook the 20-Day Moving Average

CRISPR Therapeutics AG (CRSP) Recently Broke Out Above the 50-Day Moving Average

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Recently Broke Out Above the 50-Day Moving Average

Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers

Motley Fool

4 months ago

Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers

Is CRISPR Therapeutics (CRSP) a Promising Gene Editing Stock?

Insider Monkey

4 months ago

Is CRISPR Therapeutics (CRSP) a Promising Gene Editing Stock?

CRISPR Therapeutics to Report Q3 Earnings: Is a Beat in Store?

Zacks

4 months ago

CRISPR Therapeutics to Report Q3 Earnings: Is a Beat in Store?

The Ultimate Biotech Stock to Buy With $50 Right Now

Motley Fool

4 months ago

The Ultimate Biotech Stock to Buy With $50 Right Now

CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note

Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma

Zacks

4 months ago

Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma

5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright

Zacks

4 months ago

5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Motley Fool

4 months ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know

Wall Street Analysts See a 67.54% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High?

Zacks

4 months ago

Wall Street Analysts See a 67.54% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High?

Share on Social Networks: